Display options
Share it on

Evid Based Complement Alternat Med. 2012;2012:657026. doi: 10.1155/2012/657026. Epub 2012 Jul 05.

Effects of Thymol and Carvacrol, Constituents of Thymus vulgaris L. Essential Oil, on the Inflammatory Response.

Evidence-based complementary and alternative medicine : eCAM

Fernanda Carolina Fachini-Queiroz, Raquel Kummer, Camila Fernanda Estevão-Silva, Maria Dalva de Barros Carvalho, Joice Maria Cunha, Renata Grespan, Ciomar Aparecida Bersani-Amado, Roberto Kenji Nakamura Cuman

Affiliations

  1. Department of Pharmacology and Therapeutic, State University of Maringá, 870020-900 Maringá, PR, Brazil.

PMID: 22919415 PMCID: PMC3418667 DOI: 10.1155/2012/657026

Abstract

Thyme (Thymus vulgaris L., Lamiaceae) is an aromatic and medicinal plant that has been used in folk medicine, phytopharmaceutical preparations, food preservatives, and as an aromatic ingredient. The effect of Thymus vulgaris essential oil (TEO) and its isolated constituents thymol and cavacrol (CVL) were studied in the following experimental models: ear edema, carrageenan-induced pleurisy, and chemotaxis in vitro. In the pleurisy model, TEO, CVL, and thymol significantly inhibited inflammatory edema. However, only TEO and CVL inhibited leukocyte migration. In the in vitro chemotaxis experiment, CVL inhibited leukocyte migration, whereas thymol exerted a potent chemoattractant effect. In the ear edema model, CVL (10 mg/ear), applied topically, reduced edema formation, exerting a topical anti-inflammatory effect. Thymol did not reduce edema formation but rather presented an irritative response, probably dependent on histamine and prostanoid release. Our data suggest that the antiinflammatory effects of TEO and CVL are attributable to the inhibition of inflammatory edema and leukocyte migration.

References

  1. J Pharm Pharmacol. 1964 Dec;16:810-6 - PubMed
  2. Science. 1987 Sep 4;237(4819):1171-6 - PubMed
  3. Nat Prod Commun. 2011 Jan;6(1):137-40 - PubMed
  4. Toxicon. 2011 Jun;57(7-8):984-91 - PubMed
  5. J Biol Chem. 1992 Dec 25;267(36):25934-8 - PubMed
  6. J Med Food. 2008 Dec;11(4):741-6 - PubMed
  7. J Invest Dermatol. 1985 Jul;85(1):64-9 - PubMed
  8. J Nat Med. 2011 Jan;65(1):241-6 - PubMed
  9. Nat New Biol. 1971 Jun 23;231(25):232-5 - PubMed
  10. Br J Pharmacol. 1999 Oct;128(4):853-9 - PubMed
  11. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Sep;155(3):195-218 - PubMed
  12. J Invest Dermatol. 1982 Mar;78(3):206-9 - PubMed
  13. Nat Immunol. 2001 Oct;2(10):907-16 - PubMed
  14. J Immunol. 2000 Apr 15;164(8):4321-31 - PubMed
  15. Annu Rev Immunol. 2007;25:101-37 - PubMed
  16. Planta Med. 2000 Mar;66(2):197-8 - PubMed
  17. Proc Soc Exp Biol Med. 1973 Jul;143(3):711-4 - PubMed
  18. Pharmacol Ther. 2002 Nov-Dec;96(2-3):67-202 - PubMed
  19. Br J Pharmacol Chemother. 1968 Feb;32(2):295-310 - PubMed
  20. Arq Bras Cardiol. 2010 Apr;94(4):556-63 - PubMed
  21. Biochem J. 1998 Jan 1;329 ( Pt 1):121-30 - PubMed
  22. J Appl Microbiol. 2000 Feb;88(2):308-16 - PubMed
  23. J Lipid Res. 2010 Jan;51(1):132-9 - PubMed
  24. J Ethnopharmacol. 1999 Jul;66(1):57-69 - PubMed
  25. Immunol Res. 2000;22(2-3):271-9 - PubMed
  26. J Leukoc Biol. 1993 Aug;54(2):171-8 - PubMed
  27. Food Chem Toxicol. 2002 Nov;40(11):1669-75 - PubMed
  28. Evid Based Complement Alternat Med. 2012;2012:728065 - PubMed
  29. Biochem Biophys Res Commun. 1980 Feb 12;92(3):749-56 - PubMed
  30. Nature. 2000 Aug 17;406(6797):782-7 - PubMed
  31. Arch Toxicol. 1983 Dec;54(4):275-87 - PubMed
  32. Br J Pharmacol. 1971 Jul;42(3):392-402 - PubMed
  33. Pain. 1999 Jul;82(1):81-87 - PubMed
  34. J Med Food. 2011 Sep;14(9):944-6 - PubMed
  35. Eur J Pharmacol. 2007 Aug 27;569(3):228-36 - PubMed

Publication Types